BioCentury
ARTICLE | Clinical News

Lytixar: Phase IIa start

September 13, 2010 7:00 AM UTC

This half, Lytix will begin a double-blind, placebo-controlled, Hungarian Phase IIa trial to evaluate 1, 2 and 5% topical LTX-109 in 24 patients. ...